Cegedim SA (C7E.F)
- Previous Close
11.90 - Open
12.00 - Bid 11.80 x --
- Ask 12.20 x --
- Day's Range
12.00 - 12.00 - 52 Week Range
10.25 - 14.75 - Volume
60 - Avg. Volume
14 - Market Cap (intraday)
165.887M - Beta (5Y Monthly) 1.09
- PE Ratio (TTM)
-- - EPS (TTM)
-1.10 - Earnings Date Apr 24, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 29, 2022
- 1y Target Est
--
Cegedim SA operates as a technology and services company in the field of digital data flow management for healthcare ecosystem and B2B, and business software publisher for healthcare and insurance professionals in France, other European countries, and internationally. The company operates in two segments, Health Insurance, HR and e-Services; and Healthcare Professionals. The Health Insurance, HR and e-Services segment markets various products and services to insurance companies, mutual insurers, personal protection insurers, and insurance brokers, as well as engages in the interactions between these entities and healthcare professionals. This segment also provides solutions for hosting, HR and payroll management outsourcing, electronic data exchange, and data processing services. The Healthcare Professionals division sells management software, databases, and solutions to doctors, paramedical professionals, pharmacists, and healthcare facilities. The company was incorporated in 1969 and is headquartered in Boulogne-Billancourt, France. Cegedim SA is a subsidiary of FCB SAS.
www.cegedim.com6,700
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: C7E.F
View MorePerformance Overview: C7E.F
Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: C7E.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: C7E.F
View MoreValuation Measures
Market Cap
164.50M
Enterprise Value
206.68M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.25
Price/Book (mrq)
0.62
Enterprise Value/Revenue
0.32
Enterprise Value/EBITDA
2.04
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.25%
Return on Assets (ttm)
2.46%
Return on Equity (ttm)
-4.95%
Revenue (ttm)
654.5M
Net Income Avi to Common (ttm)
-14.71M
Diluted EPS (ttm)
-1.10
Balance Sheet and Cash Flow
Total Cash (mrq)
49.58M
Total Debt/Equity (mrq)
115.34%
Levered Free Cash Flow (ttm)
12.05M